Histamine-2 Receptor Antagonists and Proton Pump Inhibitors Are Associated With Reduced Risk of SARS-CoV-2 Infection Without Comorbidities Including Diabetes, Hypertension, and Dyslipidemia: A Propensity Score-Matched Nationwide Cohort Study

CONCLUSION: H2RA and PPI use is associated with a decreased risk for SARS-CoV-2 infection but does not affect clinical outcome. Comorbidities including diabetes, hypertension, and dyslipidemia seem to offset the protective effect of H2RA and PPI.PMID:37012686 | PMC:PMC10070049 | DOI:10.3346/jkms.2023.38.e99

Source: J Korean Med Sci - April 4, 2023 Category: General Medicine Authors: Bokyung Kim Jin-Hyung Jung Kyungdo Han Seungkyung Kang Eunwoo Lee Hyunsoo Chung Sang Gyun Kim Soo-Jeong Cho Source Type: research